Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Heart Care Foundation
Study partially sponsored by: Boehringer Ingelheim, Sanofi-Aventis, Pfizer
Age
55–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
written informed consent to the study
age \>= 55 years at randomization. There is no upper age limit
systolic blood pressure \>= 150 mmHg in 2 visits at distance of 7-14 days, irrespective of diastolic pressure. Duration of treatment before visit 1 must be at least 12 weeks
at least one additional risk factor including the following:
current cigarette smoking
total cholesterol \>= 20 mmg/dl, or High Density Lipoproteins (HDL) \< 40 mg/dl, or Low Density Lipoproteins (LDL) cholesterol \>= 130 mg/dl
family history of cardiovascular disease in male first degree relative \< 55 years or female first degree relative \< 65 years
previous TIA or stroke
previous coronary artery disease
history of peripheral occlusive arterial disease (claudication intermittens associated with angiographic or echographic evidence of \> 60% stenosis)
You may not be if
diabetes (fasting glucose \> 125 mg/dl in two samples or ongoing diabetic treatment)
renal failure, defined by a serum creatinine \> 2.0 mg/dl
chronic atrial fibrillation or flutter
clinically significant hepatic or hematological disorders, alcoholism, drug addiction
causes precluding ECG interpretation for LVH: complete right or left bundle block, Wolff-Parkinson-White syndrome, previous Q-wave myocardial infarction
any disease causing reduced life expectancy
unwilling to participate
significant (more than traces of) valvular heart disease
